Loading...

MeiraGTx Holdings plc

MGTX•NASDAQ
Healthcare
Biotechnology
$9.41
$0.19(2.06%)
U.S. Market opens in 6h 22m

MeiraGTx Holdings plc (MGTX) Stock Overview

Explore MeiraGTx Holdings plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap871M
P/E Ratio-6.71
EPS (TTM)$-1.42
ROE44.39%
Fundamental Analysis

AI Price Forecasts

1 Month$6.84
3 Months$5.54
1 Year Target$10.53

MGTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MeiraGTx Holdings plc (MGTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.71 and a market capitalization of 871M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.06%
5-Day Change
-0.11%
1-Month Change
3.52%
3-Month Change
23.65%
6-Month Change
3.63%
Year-to-Date (YTD) Change
18.36%
1-Year Change
29.61%
3-Year Change
72.34%
5-Year Change
-34.65%
All-Time (Max) Change
-37.27%

Contact Information

https://www.meiragtx.com
646 860 7985
430 East 29th Street, New York City, NY, 10016

Company Facts

375 Employees
IPO DateJun 8, 2018
CountryUS
Actively Trading

Frequently Asked Questions